Distinguishing classes of neuroactive drugs based on computational physicochemical properties and experimental phenotypic profiling in planarians.

Abstract excerpt

Mental illnesses put a tremendous burden on afflicted individuals and society. Identification of novel drugs to treat such conditions is intrinsically challenging due to the complexity of neuropsychiatric diseases and the need for a systems-level understanding that goes beyond single molecule-target interactions. Thus far, drug discovery approaches focused on target-based in silico or in vitro high-throughput...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to bioluminescence and chemiluminescence research
• Share to Cholinesterase and Neurodegenerative Diseases